Refine by
Chronic Discogenic Low Back Pain Suppliers & Manufacturers
6 companies found
based inDublin 2, IRELAND
We are a global medical device company offering therapeutic solutions and new hope for adults suffering from chronic pain. We aim to transform patients’ lives everyday by alleviating pain and improving function. Mainstay Medical is led by a team of ...
For too long, you have suffered from Chronic Low Back Pain (CLBP) and nothing has provided you with lasting or meaningful relief. One reason may be the muscles in your low back that normally prevent painful movements are not working properly. But ...
based inAnn Arbor, MISSISSIPPI (USA)
AxioBionics is a leader in the development and implementation of advanced medical devices designed to improve the quality of life for individuals with musculoskeletal and nervous system disorders. The company focuses on harnessing the innate ...
The BioBelt, developed by AxioBionics, targets chronic low back pain through innovative electrical stimulation technology. Uniquely engineered, these FDA-cleared devices provide an alternative to traditional pain management by modulating the nervous ...
based inMinneapolis, MINNESOTA (USA)
Relievant Medsystems is a privately held medical device company with headquarters in Minneapolis, MN. Based on two decades of research, we developed the Intracept Procedure — a minimally invasive procedure that targets the basivertebral nerve for ...
The Intracept Procedure for the Relief of Chronic Vertebrogenic Low Back Pain. The Intracept Procedure is a minimally invasive procedure that targets the basivertebral nerve for the relief of chronic vertebrogenic low back ...
based inMabou, NOVA SCOTIA (CANADA)
Halifax Biomedical Inc. (HBI) is an Evidence Based Orthopaedic clinical measurements company headquartered in Nova Scotia, Canada with its US office located in Cambridge, MA. HBI is a world leading provider of micro-instability assessment services ...
based inCheshire, UNITED KINGDOM
Founded in 2012 at University of Manchester, Gelmetix is a UK medtech company focused on treating chronic lower back pain caused by the degeneration of the intervertebral discs. Gelmetix’s polymer gel technology also has the potential to be adapted ...
A focus on low-back pain. About 40% of chronic low-back pain is the result of degenerative disc disease3. Gelmetix’s double cross-linked microgel (DXM) is a biological solution that addresses the source of pain. In the intervertebral disc it ...
based inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
Mesoblast has a strong and extensive global intellectual property (IP) portfolio with protection extending through to at least 2040 in all major markets. This IP position is expected to provide the Company with substantial commercial advantages as ...